Financhill
Sell
38

VREX Quote, Financials, Valuation and Earnings

Last price:
$14.72
Seasonality move :
-0.72%
Day range:
$14.15 - $14.72
52-week range:
$10.19 - $21.06
Dividend yield:
0%
P/E ratio:
17.52x
P/S ratio:
0.74x
P/B ratio:
1.13x
Volume:
324.2K
Avg. volume:
713.1K
1-year change:
-27.79%
Market cap:
$604.6M
Revenue:
$811M
EPS (TTM):
-$1.17

Analysts' Opinion

  • Consensus Rating
    Varex Imaging has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of --, Varex Imaging has an estimated upside of 50.92% from its current price of $14.71.
  • Price Target Downside
    According to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $14.71.

Fair Value

  • According to the consensus of 0 analysts, Varex Imaging has 50.92% upside to fair value with a price target of -- per share.

VREX vs. S&P 500

  • Over the past 5 trading days, Varex Imaging has underperformed the S&P 500 by -5.75% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Varex Imaging does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Varex Imaging revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Varex Imaging reported revenues of $205.7M.

Earnings Growth

  • Varex Imaging earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Varex Imaging reported earnings per share of -$1.22.
Enterprise value:
861.6M
EV / Invested capital:
0.87x
Price / LTM sales:
0.74x
EV / EBIT:
27.09x
EV / Revenue:
1.06x
PEG ratio (5yr expected):
0.70x
EV / Free cash flow:
42.23x
Price / Operating cash flow:
29.58x
Enterprise value / EBITDA:
13.70x
Gross Profit (TTM):
$256.9M
Return On Assets:
-3.84%
Net Income Margin (TTM):
-5.88%
Return On Equity:
-8.23%
Return On Invested Capital:
-4.66%
Operating Margin:
5.3%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $859.4M $893.4M $811M $227.4M $205.7M
Gross Profit $283.5M $290.3M $256.9M $78M $67.1M
Operating Income $88.2M $77.1M $32.1M $24.3M $10.9M
EBITDA $114.5M $91.2M $62.9M $16.3M $16M
Diluted EPS $0.73 $1.05 -$1.17 $0.66 -$1.22
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $522M $554.2M $609.9M $658.3M $649.9M
Total Assets $1.1B $1.1B $1.2B $1.2B $1.2B
Current Liabilities $160.6M $166.6M $173.1M $162.8M $195.9M
Total Liabilities $673.7M $651M $637.7M $668.6M $667.8M
Total Equity $465.8M $496.5M $546.7M $581M $549.2M
Total Debt $455.3M $434.5M $414.4M $442.6M $443.4M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations $16.9M $108.4M $47.3M $47.1M $25.9M
Cash From Investing -$48.4M -$44.9M -$27.5M -$14.6M -$14M
Cash From Financing -$23.8M -$200K -$3.3M $1.4M $800K
Free Cash Flow -$4.4M $87.7M $20.4M $41.7M $19.9M
VREX
Sector
Market Cap
$604.6M
$46.1M
Price % of 52-Week High
69.85%
46.02%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
-27.79%
-30.52%
Beta (5-Year)
0.603
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $14.69
200-day SMA
Buy
Level $14.46
Bollinger Bands (100)
Buy
Level 11.31 - 14.79
Chaikin Money Flow
Buy
Level 3.4M
20-day SMA
Sell
Level $15.49
Relative Strength Index (RSI14)
Sell
Level 46.50
ADX Line
Buy
Level 14.99
Williams %R
Neutral
Level -71.6738
50-day SMA
Buy
Level $14.41
MACD (12, 26)
Sell
Level -0.08
25-day Aroon Oscillator
Buy
Level 28
On Balance Volume
Sell
Level -652.3K

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.7214)
Sell
CA Score (Annual)
Level (-0.3338)
Buy
Beneish M-Score (Annual)
Level (-2.8994)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.6858)
Sell
Piotroski F Score (Annual)
Level (3)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.

Stock Forecast FAQ

In the current month, VREX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The VREX average analyst price target in the past 3 months is --.

  • Where Will Varex Imaging Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Varex Imaging share price will rise to -- per share over the next 12 months.

  • What Do Analysts Say About Varex Imaging?

    Analysts are divided on their view about Varex Imaging share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Varex Imaging is a Sell and believe this share price will drop from its current level to --.

  • What Is Varex Imaging's Price Target?

    The price target for Varex Imaging over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is VREX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Varex Imaging is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of VREX?

    You can purchase shares of Varex Imaging via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Varex Imaging shares.

  • What Is The Varex Imaging Share Price Today?

    Varex Imaging was last trading at $14.72 per share. This represents the most recent stock quote for Varex Imaging. Yesterday, Varex Imaging closed at $14.71 per share.

  • How To Buy Varex Imaging Stock Online?

    In order to purchase Varex Imaging stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Is Alphabet an Undervalued Growth Stock to Buy?
Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 118x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
87
PSIX alert for Dec 25

Power Solutions International [PSIX] is up 27.42% over the past day.

Buy
65
TSLL alert for Dec 25

Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.

Buy
75
SMLR alert for Dec 25

Semler Scientific [SMLR] is up 15.37% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock